Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mailin Ashoff"'
Autor:
Carina Hage, Sabine Hoves, Mailin Ashoff, Veronika Schandl, Stefan Hört, Natascha Rieder, Christian Heichinger, Marco Berrera, Carola H Ries, Fabian Kiessling, Thomas Pöschinger
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219517 (2019)
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has a high mortality rate due to limited treatment options. Hence, the response of HCC to different cancer immunotherapies is being intensively investigated in clinical tr
Externí odkaz:
https://doaj.org/article/32aaa4fc8bf8483789acc338886f0921
Autor:
Sabine Hoves, Veronika Schandl, Natascha Rieder, Marco Berrera, Christian Heichinger, Stefan Hört, Carina Hage, Thomas Pöschinger, Fabian Kiessling, Carola Ries, Mailin Ashoff
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219517 (2019)
PLOS ONE 14(7), e0219517 (2019). doi:10.1371/journal.pone.0219517
PLoS ONE
PLOS ONE 14(7), e0219517 (2019). doi:10.1371/journal.pone.0219517
PLoS ONE
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has a high mortality rate due to limited treatment options. Hence, the response of HCC to different cancer immunotherapies is being intensively investigated in clinical tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::badf2fccee6f18b772cbbe1b127179fa
https://doaj.org/article/32aaa4fc8bf8483789acc338886f0921
https://doaj.org/article/32aaa4fc8bf8483789acc338886f0921
Autor:
Thomas Schmitt, Mailin Ashoff
Publikováno v:
Annales Zoologici Fennici. 51:413-422
Polymorphisms are widely known in allozymes and are often assumed neutral in the context of phylogenetic and population genetic analyses. However, several studies revealed that, in some loci and species, selection is strongly acting on allozymes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae7772b98d56f3d3f9c31ebed955a49c
https://doi.org/10.5735/086.051.0502
https://doi.org/10.5735/086.051.0502
Autor:
Thomas Pöschinger, Fabian Kiessling, Mario Perro, Frank Herting, Leanne Strauss, Carina Hage, Mailin Ashoff, Sabine Hoves
Publikováno v:
Cancer Research. 78:4084-4084
Introduction Immunotherapy is a promising treatment strategy for hepatocellular carcinoma (HCC). A phase III trial for advanced HCC shows favorable results for nivolumab compared to sorafenib. In order to evaluate the outcome of different therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82aee235adcbf953cac8d8a14e4b615c
https://doi.org/10.1158/1538-7445.am2018-4084
https://doi.org/10.1158/1538-7445.am2018-4084